U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Merck KGaA

Market Cap: US$48.0b

Operates as a science and technology company in Germany.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Regeneron Pharmaceuticals

Market Cap: US$53.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Merck

Market Cap: US$198.5b

Operates as a healthcare company worldwide.

United Therapeutics

Market Cap: US$13.1b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Exact Sciences

Market Cap: US$10.0b

Provides cancer screening and diagnostic test products in the United States and internationally.

Anika Therapeutics

Market Cap: US$151.9m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Jazz Pharmaceuticals

Market Cap: US$6.5b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Bristol-Myers Squibb

Market Cap: US$95.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Decibel Cannabis

Market Cap: US$40.4m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Teva Pharmaceutical Industries

Market Cap: US$19.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BeOne Medicines

Market Cap: US$29.3b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Bio-Rad Laboratories

Market Cap: US$6.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

ANI Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Evolus

Market Cap: US$598.3m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

ICON

Market Cap: US$11.6b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Perrigo

Market Cap: US$3.6b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Sanofi

Market Cap: US$101.4b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Amneal Pharmaceuticals

Market Cap: US$2.5b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Trulieve Cannabis

Market Cap: US$903.9m

Operates as a cannabis retailer.

Evotec

Market Cap: US$1.2b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Halozyme Therapeutics

Market Cap: US$6.5b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Biogen

Market Cap: US$18.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Royalty Pharma

Market Cap: US$19.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Organon

Market Cap: US$2.5b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Viatris

Market Cap: US$10.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Curaleaf Holdings

Market Cap: US$818.0m

Produces and distributes cannabis products in the United States and internationally.

Avantor

Market Cap: US$9.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Cresco Labs

Market Cap: US$272.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

AVITA Medical

Market Cap: US$137.0m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Bayer

Market Cap: US$26.2b

Operates as a life science company worldwide.

Tilray Brands

Market Cap: US$359.8m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

UroGen Pharma

Market Cap: US$675.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Cytek Biosciences

Market Cap: US$373.6m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

High Tide

Market Cap: US$248.0m

Engages in the cannabis retail business in Canada, the United States, and internationally.